InvestorsHub Logo
icon url

falconer66a

01/23/17 8:59 PM

#88558 RE: Reyeton #88557

New Insurance Coverage

Perhaps insurance companies would be quick to authorize and cover off-label Anavex2-73 prescriptions, once it was discovered, even in the absence of FDA approval, that it markedly stabilized or reduced Alzheimer's symptoms, thereby reducing subsequent medical costs for the insurance company.

Perhaps all parties can win.